Immune-related adverse events: Comparison of melanoma and non-small cell lung cancer patients treated with anti-PD1 therapy

N. Duma; A. G. Azzouqa; S. Yadav; K. Hoversten; C. Reed; A. N. Sitek; Y. Lou; J. Molina; T. Halfdanarson; K. Leventakos; R. W. Joseph; R. Manochakian; R. Dronca

doi:10.1093/annonc/mdy288.089

Immune-related adverse events: Comparison of melanoma and non-small cell lung cancer patients treated with anti-PD1 therapy

N. Duma, A. G. Azzouqa, S. Yadav, K. Hoversten, C. Reed, A. N. Sitek, Y. Lou, J. Molina, T. Halfdanarson, K. Leventakos, R. W. Joseph, R. Manochakian, R. Dronca

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	viii432
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy288.089
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy288.089

Cite this

Duma, N., Azzouqa, A. G., Yadav, S., Hoversten, K., Reed, C., Sitek, A. N., Lou, Y., Molina, J., Halfdanarson, T., Leventakos, K., Joseph, R. W., Manochakian, R., & Dronca, R. (2018). Immune-related adverse events: Comparison of melanoma and non-small cell lung cancer patients treated with anti-PD1 therapy. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii432. https://doi.org/10.1093/annonc/mdy288.089

Duma, N, Azzouqa, AG, Yadav, S, Hoversten, K, Reed, C, Sitek, AN, Lou, Y , Molina, J, Halfdanarson, T, Leventakos, K, Joseph, RW, Manochakian, R & Dronca, R 2018, 'Immune-related adverse events: Comparison of melanoma and non-small cell lung cancer patients treated with anti-PD1 therapy', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii432. https://doi.org/10.1093/annonc/mdy288.089

@article{6c8d7da3401c4da3ad129ecf702dc5cb,

title = "Immune-related adverse events: Comparison of melanoma and non-small cell lung cancer patients treated with anti-PD1 therapy",

author = "N. Duma and Azzouqa, {A. G.} and S. Yadav and K. Hoversten and C. Reed and Sitek, {A. N.} and Y. Lou and J. Molina and T. Halfdanarson and K. Leventakos and Joseph, {R. W.} and R. Manochakian and R. Dronca",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy288.089",

language = "English (US)",

volume = "29",

pages = "viii432",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Immune-related adverse events

T2 - Comparison of melanoma and non-small cell lung cancer patients treated with anti-PD1 therapy

AU - Duma, N.

AU - Azzouqa, A. G.

AU - Yadav, S.

AU - Hoversten, K.

AU - Reed, C.

AU - Sitek, A. N.

AU - Lou, Y.

AU - Molina, J.

AU - Halfdanarson, T.

AU - Leventakos, K.

AU - Joseph, R. W.

AU - Manochakian, R.

AU - Dronca, R.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85080063078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85080063078&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy288.089

DO - 10.1093/annonc/mdy288.089

M3 - Article

C2 - 32137099

SN - 0923-7534

VL - 29

SP - viii432

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Immune-related adverse events: Comparison of melanoma and non-small cell lung cancer patients treated with anti-PD1 therapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this